Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANGIODYNAMICS INC Director's Dealing 2014

Aug 8, 2014

32939_dirs_2014-08-08_1bd0531f-37d7-49de-82bf-5190e41cd13a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2014-08-03

Reporting Person: Richard Stark (SVP, GM - Oncology)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-08-03 Common Stock F 357 $14.69 Disposed 31249 Direct
2014-08-03 Common Stock F 759 $14.69 Disposed 30490 Direct
2014-08-03 Common Stock F 893 $14.69 Disposed 29597 Direct
2014-08-06 Common Stock F 477 $14.75 Disposed 29120 Direct

Footnotes

F1: The exempt disposition of 357 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on August 3, 2010.

F2: The exempt disposition of 759 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on August 3, 2011.

F3: The exempt disposition of 893 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on August 17, 2012.

F4: The exempt disposition of 477 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on August 6, 2013.